Screener
Alto Neuroscience ANRO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (16) | (22) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | 87,278 | (7,475) |
| Cash, cash equivalents and restricted cash at the beginning of the period | 176,984 | 168,729 |
| Cash, cash equivalents and restricted cash at the end of the period | $264,262 | $161,254 |
| Supplemental Disclosure of Non-cash Activities | ||
| Conversion of K2 term loan into shares of common stock | $941 | — |
| Costs from sale of common stock and pre-funded warrants in 2026 private placement not yet paid | $233 | — |
| Deferred offering and share issue costs not yet paid | — | $138 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Alto Neuroscience's cash & equivalents?
- Alto Neuroscience (ANRO) reported cash & equivalents of $264.26M in Q1 2026.
- How has Alto Neuroscience's cash & equivalents changed year-over-year?
- Alto Neuroscience's cash & equivalents increased by 63.9% year-over-year, from $161.25M to $264.26M.
- What is the long-term trend for Alto Neuroscience's cash & equivalents?
- Over 3 years (2022 to 2025), Alto Neuroscience's cash & equivalents has grown at a 54.1% compound annual growth rate (CAGR), from $48.34M to $176.98M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Alto Neuroscience's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude